Apollo Endosurgery

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

At Apollo Endosurgery, our mission is to bring innovative, minimally-invasive therapies to people around the world for the treatment of obesity and other gastrointestinal diseases.

Our vision is to become a world leader in the development and manufacturing of endoscopic and laparoscopic surgical technology that improves healthcare delivery and patient outcomes.

Apollo Endosurgery has been recognized for its innovation in medical technology with numerous awards from the Food and Drug Administration , including “Breakthrough Device” designation for its gastric balloon product for weight loss, “Humanitarian Use Device” designation for its cervical esophagogastric anastomosis device, and the prestigious “Innovations in Medical Technology Award” from the FDA’s Center for Devices and Radiological Health in 2017.